In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback